Mainstream

Protalix BioTherapeutics GAAP EPS of $0.00 misses by $0.03, revenue of $15.66M beats by $2.18M

Protalix BioTherapeutics GAAP EPS of $0.00 misses by $0.03, revenue of $15.66M beats by $2.18M

Post ContentplxRead More

You might also be interested in reading BlackRock’s GIP acquires 49.99% stake in Eni’s carbon capture and storage business.

August 14, 2025
In Mainstream